Purpose. To investigate the potential use of polymeric nanoparticles for th
e delivery of antisense oligonucleotides in HIV-1-infected cell cultures.
Methods. Phosphorothioate oligonucleotides were encapsulated into poly (D,L
-lactic acid) nanoparticles. Two models of infected cells were used to test
the ability of nanoparticles to deliver them. HeLa P4-2 CD4+ cells, stably
transfected with the P-galactosidase reporter gone, were first used to eva
luate the activity of the oligonucleotides on a single-round infection cycl
e. The acutely infected lymphoid CEM cells were then used to evaluate the i
nhibition of the viral production of HIV-1 by the oligonucleotides.
Results. The addition to infected CENT cells of nanoparticles containing ga
g antisense oligonucleotides in the nanomolar range led to strong inhibitio
n of the viral production in a concentration-dependent manner. Similar resu
lts were previously observed in HeLa P4-2 CD4+ cells. Nanoparticle-entrappe
d random-order gag oligonucleotides had similar effects on reverse transcri
ption. However, the reverse transcriptase activity of infected cells treate
d with nanomolar concentrations of free antisense and random oligonucleotid
es was not affected.
Conclusions. These results suggest that poly (D,L-lactic acid) nanoparticle
s may have great potential as an efficient delivery system for oligonucleot
ides in HIV natural target cells, i.e., lymphocytic cells.